Examining Charitable Giving and Trends in the Nonprofit Sector March 17, 2022, 10:00 a.m. United States Senate Committee on FinanceRandall L. RuttaChief Executive Officer 1730 M St NW, Suite 500Washington, […]
PDUFA
Statement for the Record: FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics
Statement for the Record: FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics February 3, 2022, 10:30 a.m. United States House Committee on Energy and CommerceRandall L. RuttaChief […]
NHC Comments on PDUFA Reauthorization Performance Goals and Procedures FY 2023-2027
PDF Version October 28, 2021 Janet Woodcock, MD Acting Commissioner US Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 RE: PDUFA Reauthorization Performance Goals and Procedures […]
NHC Comments on PDUFA VII Public Stakeholder Meeting
By Maddie Mason, Senior Associate, Policy The National Health Council (NHC) submitted comments last week to the Food and Drug Administration (FDA) on their July 23 Public Stakeholder Meeting on the Prescription Drug User Fee Act (PDUFA) VII where NHC […]